Cover image of the article: Hepatitis C Virus infections trends in Italy, 1996-2006

Image Credit:Hepat Mon

Hepatitis C Virus infections trends in Italy, 1996-2006

Authors

Malgorzata pilarczyk, Anna Foksinska, ewa Smukalska, Waldemar Halota, Małgorzata PawłowskaMałgorzata Pawłowska ORCID1,*
1Department of Infectious Diseases and Hepatology, Collegium Medicum, n.Copernicus University, Bydgoszcz, poland
*Corresponding Author: : Malgorzata pawlowska, Department of Children Infectious Diseases and Hepatology Collegium Medicum n. Copernicus University, Floriana 12, 85-030 Bydgoszcz, poland. Tel: +48-523255683, +48- 523255605, Fax: +48-523457195, Email: mpawlowska@cm.umk.pl

Hepatitis Monthly:Vol. 11, issue 12; 895-900
Published online:Nov 30, 2011
Article type:Research Article
Received:Jun 07, 2011
Accepted:Aug 18, 2011
How to Cite:pilarczyk M, Foksinska A, Smukalska E, Halota W, Pawłowska M. Hepatitis C Virus infections trends in Italy, 1996-2006. Hepat Mon. 2011;11(12):. doi: https://doi.org/10.5812/kowsar.1735143X.789

Abstract

 

Background: The World Health Organization (WHO) estimates that about 180 million people, 3% of the world population, are infected with the hepatitis C virus (HCV). In Italy, the prevalence in the general population is reported to be greater than 5% and 9% among households of HCV-positive patients.
Objectives: The aim of this study was to estimate the trends of HCV infection in Italy in the period 1996-2006.
Materials and Methods: The formula ln (rate) = b × years was applied for logarithmic transformation of the incidence rates to obtain time trends of HCV infection, using the joinpoint regression program software version 3.3.1. Linear graphs representing trends and the annual percentage change (APC) were considered for each joinpoint. Time changes are expressed as expected annual percentage change (EAPC) with the respective 95% confidence intervals (CIs); significance levels of time trends are also reported. The null hypothesis was tested using a maximum of 3 changes in slope with an overall significance level of 0.05 divided by the number of joinpoints in the final model.
Results: Considering all age groups, the incidence rate decreased from 2.02 to 0.55 per 100,000. The joinpoint analysis showed a statistically significant decrease in the incidence rates of HCV infection. No joinpoints were found in any age groups. Our data show that the incidence rates of HCV infections have considerably decreased in each age group throughout the studied period (1996-2006).
Conclusions: This decreasing trend in HCV infections is, in part, attributable to behavioral and social changes. Improved hygiene, use of precautions in medical settings, blood screening, and sexual educational campaigns seem to have contributed to reduce the transmission of infection during the last 10 years.

 

Highlights

Fulltext

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Nov
2011
Hepatitis C Virus infections trends in Italy, 1996-2006

Hepatitis C Virus infections trends in Italy, 1996-2006

Maria Gualano,
Leda Semyonov,
Nicola Nicolotti,
Walter Ricciardi,
Antonio Boccia,
Giuseppe Torre

Gualano M, Semyonov L, Nicolotti N, Ricciardi W, Boccia A, et al. Hepatitis C Virus infections trends in Italy, 1996-2006. Hepat Mon. 2011;11(11):. doi: https://doi.org/10.5812/kowsar.1735143X.767

3
Sep
2024
Changing Epidemiology of Chronic Hepatitis C: A University Hospital Experience

Changing Epidemiology of Chronic Hepatitis C: A University Hospital Experience

Süheyla Kömür,
Behice Kurtaran,
Yusuf Kemal Arslan,
Ferit Kuscu,
Sezin Hoşgel Sevdimbaş,
Seza Ayse Inal
,et al.

Kömür S, Kurtaran B, Kemal Arslan Y, Kuscu F, Hoşgel Sevdimbaş S, et al. Changing Epidemiology of Chronic Hepatitis C: A University Hospital Experience. Hepat Mon. 2024;24(1):e148127. doi: https://doi.org/10.5812/hepatmon-148127

27
Aug
2013
Mortality Trend for Tumor Correlated Immune System in Hyperendemic Area of HCV Infection in Southern Italy: Joinpoint Analysis

Mortality Trend for Tumor Correlated Immune System in Hyperendemic Area of HCV Infection in Southern Italy: Joinpoint Analysis

Maurizio Montella,
Matteo Malvezzi,
Maria Grimaldi,
Flavia Nocerino,
Ferdinando Frigeri,
Antonio Pinto
,et al.

Montella M, Malvezzi M, Grimaldi M, Nocerino F, Frigeri F, et al. Mortality Trend for Tumor Correlated Immune System in Hyperendemic Area of HCV Infection in Southern Italy: Joinpoint Analysis. Hepat Mon. 2013;13(8):e12725. doi: https://doi.org/10.5812/hepatmon.12725

25
Jul
2016
Trends in the Incidence Rates of Chronic Hepatitis B in Poland in the Years 2005 - 2013

Trends in the Incidence Rates of Chronic Hepatitis B in Poland in the Years 2005 - 2013

Barbara Stawinska-Witoszynska,
Monika Zysnarska,
Małgorzata Krzywinska-Wiewiorowska,
Paulina Wojtyła-Buciorab,
Alicja Krzyzaniak,
Barbara Wieckowska

Stawinska-Witoszynska B, Zysnarska M, Krzywinska-Wiewiorowska M, Wojtyła-Buciorab P, Krzyzaniak A, et al. Trends in the Incidence Rates of Chronic Hepatitis B in Poland in the Years 2005 - 2013. Hepat Mon. 2016;16(8):e32692. doi: https://doi.org/10.5812/hepatmon.32692

8
Sep
2025
Epidemiology of the Incidence, Prevalence and Burden of Hepatitis C (HC) and Relationship to Human Development Index (HDI) in Iran During 1990 - 2019

Epidemiology of the Incidence, Prevalence and Burden of Hepatitis C (HC) and Relationship to Human Development Index (HDI) in Iran During 1990 - 2019

Soheila Abolghasemi,
Changiz Rostami,
Elham Goudarzi

Abolghasemi S, Rostami C, Goudarzi E. Epidemiology of the Incidence, Prevalence and Burden of Hepatitis C (HC) and Relationship to Human Development Index (HDI) in Iran During 1990 - 2019. Koomesh. 2025;27(5):e149284. doi: https://doi.org/10.69107/koomesh-149284

More by these authors

Malgorzata pilarczykPubMedScholar
Anna FoksinskaPubMedScholar
ewa SmukalskaPubMedScholar
Waldemar HalotaPubMedScholar
Małgorzata PawłowskaPubMedScholar
Share
Cited by
Metrics